Related Experiment Video
Updated: Dec 4, 2025

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation
Jiatian Lin1, Xiaoqin Fan2, Junhui Chen1
1Department of Minimally Invasive Intervention, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Abstract:
Colorectal cancer (CRC) is the third most common cancer in the world and its development is associated with oncogenic dysfunction. Therefore, the present study aimed to identify differentially expressed genes (DEGs) in CRC tissues and to determine the role of keratin 80 (KRT80) in CRC cell proliferation. DEGs were initially screened in 32 paired CRC tissues and matched adjacent normal tissues from RNA-Seq datasets in The Cancer Genome Atlas database using the limma package in R software. In total, 2,114 DEGs were identified, of which KRT80 was discovered to be the most upregulated in CRC tissues. Moreover, increased KRT80 expression levels were confirmed in tissues collected from 50 patients with CRC using reverse transcription-quantitative PCR, and its increased expression levels were significantly associated with increased lymph node and distant metastasis and a higher pathological stage. Furthermore, KRT80 knockdown using siRNA decreased the viability and proliferation of CRC cells. Finally, pathway analysis revealed that the proteins co-expressed with KRT80 in CRC were enriched in the cell cycle, DNA replication, immune system, metabolism of protein and RNA, signal transduction and other cellular processes. Among them, the cell cycle and DNA replication pathways contained the highest number of the proteins identified. In conclusion, the findings of the present study suggested that KRT80 may be overexpressed in CRC tissues. Furthermore, KRT80 may be involved in the proliferation of CRC cells, which is likely through its ability to regulate the cell cycle and DNA replication pathways, thus it may serve as a potential therapeutic target for patients with CRC.
Insights
Keratin 80 (KRT80) is highly expressed in colorectal cancer (CRC) and promotes cancer cell proliferation. Targeting KRT80 may offer a new therapeutic strategy for CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a leading cause of cancer death globally.
- Oncogenic dysfunction drives CRC development.
- Identifying novel molecular targets is crucial for CRC treatment.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) in colorectal cancer (CRC) tissues.
- To investigate the role of keratin 80 (KRT80) in CRC cell proliferation.
- To explore KRT80 as a potential therapeutic target for CRC.
Main Methods:
- RNA-sequencing (RNA-Seq) analysis of 32 paired CRC tissues and adjacent normal tissues.
- Differential gene expression analysis using the limma package in R.
- Validation of KRT80 expression in 50 CRC patient tissues via reverse transcription-quantitative PCR (RT-qPCR).
- Functional studies involving KRT80 knockdown using small interfering RNA (siRNA).
- Bioinformatic pathway analysis of KRT80 co-expressed proteins.
Main Results:
- Identified 2,114 differentially expressed genes (DEGs) in CRC.
- KRT80 was the most significantly upregulated gene in CRC tissues.
- Elevated KRT80 expression correlated with advanced lymph node metastasis, distant metastasis, and higher pathological stage.
- KRT80 knockdown suppressed CRC cell viability and proliferation.
- Pathway analysis indicated KRT80 is involved in cell cycle and DNA replication regulation.
Conclusions:
- KRT80 is frequently overexpressed in colorectal cancer (CRC) tissues.
- KRT80 plays a significant role in promoting CRC cell proliferation.
- KRT80's involvement in cell cycle and DNA replication pathways suggests its potential as a therapeutic target for CRC.
More Related Videos
Related Concept Videos
Experimental RNAi
MicroRNAs
MicroRNAs
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

